Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic.

Slides:

Advertisements

Similar presentations

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Diphtheria Incidence in the WHO European Region 1990 Source; WHO/UNICEF.

Advertisements

1 |1 | Countries using and planning to introduce IPV July 2014 status report This slide deck provides a summary per country on the status of planning for.

Monitoring progress towards the coverage and disease incidence targets GLOBAL MEASLES AND RUBELLA MANAGEMENT MEETING March 2011 Geneva, Switzerland.

Vaccine in National Immunization Programme Update March 2015.

1 |1 | Countries using and planning to introduce IPV.

1 |1 | Countries using and planning to introduce IPV.

World Health Organization

TITLE from VIEW and SLIDE MASTER | August 7, |1 | Countries with Hib vaccine in the national immunization programme; and planned introductions *

WHO Regional Office for Europe Vaccine preventable diseases and Immunization programme Measles containing vaccine (MCV1) coverage in the WHO European Region.

Evidence and Information for Policy The World Health Survey Health System Metrics Glion, September 2006.

The Global Plan to Stop TB, (1)

1 Global and Regional Tuberculosis (TB) update ACSM workshop, Amman, Jordan April 13-17, 2008 Dr. Sevil Huseynova.

World Health Organization

Disclaimer the boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the.

Highlights of New WPV Cases 34 new cases in 5 countries 14 cases (14 W3) but no new district in India Most recent date of onset 03 Oct 1 case (W1) but.

Data in WHO HQ as of 09 October 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this.

DOTS Expansion: Monitoring Drugs Leopold Blanc TBS, Stop TB WHO, Communicable Diseases.

Evidence and Information for Policy Christopher J.L. Murray Executive Director Evidence and Information for Policy World Health Organization National Capacity.

World Health Assembly 63 Geneva, Suisse May 2010 WORLD HEALTH EDITORS NETWORK Tracking Global Health News: building health literacy Multi-Drug Resistant.

Global Programme on Evidence for Health Policy Presentation by the Epidemiology and Burden of Disease Team of the World Health Organization at the United.

Global Programme on Evidence for Health Policy Mapping Poverty: Predicting Income using the LandScan Database Workshop on Gridding Population Data CIESIN,

Data in WHO HQ as of 17 Apr 2012 Highlights of New Wild Poliovirus Cases The boundaries and names shown and the designations used in the maps in this document.

WHO and International Panel International Collaborative Effort on Injury Statistics Hyatt Regency, Washington September 7-8, 2006.

Dr Ral Antic Chair Scientific Committee IUATLD-APR Australia Pre-Conference Workshop 1 National TB Control Program Summary & Remarks.

Measles Mortality Reduction: the risk of resurgence Global Immunization Meeting Geneva, Switzerland 1-3 February 2010 Balcha Masresha, WHO/AFRO.

Vaccine in National Immunization Programme Update April 2016.

World Health Organization

SAGE 2010 Sampling Distribution

WHO The World Health Survey General Introduction

financial requirements

Measles disease An acute viral infection spread via respiratory secretions or aerosols Classic manifestations: Maculopapular rash Fever +cough + coryza/conjuctivities.

reporting rate of discarded cases* per 100'000 population**

Ageing Matters Somnath Chatterji Information, Evidence and Research

Alarcos Cieza, MSc, MPH, PhD Coordinator Disability and Rehabilitation

World Health Organization

Monthly Distribution of Wild Poliovirus Cases1,

SAGE 2009 Sampling Distribution

06/12/2018 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Countries Having Introduced Hib Vaccine

Countries Having Introduced Hib Vaccine and Infant Hib Coverage, 2010

Sampling Distribution

15/01/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.

Non-polio AFP Rate July 2014 – June 2015 July 2015 – June 2016

Monthly Distribution of Wild Poliovirus Cases1,

(70 countries or 36%) (23 countries or 12%)

Countries with Genotype data available

Countries Using Hib Vaccine in National Immunization Schedule in 2010 and Countries Approved for GAVI Support for Use from 2011 Onwards Yes (166 countries.

World Health Organization

24/02/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

World Health Organization

Onset of most recent WPV1 Case Number of WPV infected districts

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Countries having introduced HepB vaccine

No new positives this week

05/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

Most-affected regions in the Russian Federation

08/04/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week The boundaries and names shown and the designations used in.

Mapping Levels of Palliative Care Development: A Global Update

Countries Using Mening Vaccine in National Immunization Schedule 2011

- Use same categories as for bar chart below Introduced Without GAVI

Onset of most recent case Number of infected districts

04/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1contacts of positive AFP cases, community, healthy children.

THE GLOBAL EPIDEMIOLOGY OF TUBERCULOSIS WORLD HEALTH ORGANIZATION

Meningitis/Encephalitis Surveillance Countries reporting to WHO Network or with Other (non-WHO Network) Surveillance Activities WHO Network (46 member.

16/05/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

27/08/2019 Highlights of New Wild Poliovirus and cVDPV Positives Reported Globally this Week 1Environmental sampling, contacts of AFP cases, community.

2,100 4,200 1,050 Kilometers < 90% (75 countries or 39%)

World Health Organization

Attachment B-3: Animation of 137Cs deposition on ground/sea surface

World Health Organization

Presentation transcript:

Global Programme on Evidence for Health Policy The use of GIS in the Global Programme on Evidence for Health Policy (GPE) Meeting on Cartography and Geographic Information Science UN Headquarters, New York march 2000

Global Programme on Evidence for Health Policy WHO Structure Where is GPE ? Health Systems and Community Health Communicable Diseases Sustainable Development and Healthy Environments Health Technology and Pharmaceuticals Non- communicable Diseases and Mental Health Evidence and Information for Policy External Relations and Governing Bodies General Management Cabinet Director-General Link to Regional Directors

Global Programme on Evidence for Health Policy Mission of GPE Strengthen the scientific and ethical foundations for evidence-based policy formulation

Global Programme on Evidence for Health Policy Organization of GPE Assessing Health Needs: Epidemiology and Burden of Disease (EBD) Choosing Interventions: Effectiveness, Quality, Cost, Gender and Ethics (EQC) Designing Policy Options: Financing, Resource Allocation, Regulation and Legislation (FAR)

Global Programme on Evidence for Health Policy Thematic mapping GIS in GPE Objectives Risk mapping

Global Programme on Evidence for Health Policy GIS in GPE Risk mapping

Global Programme on Evidence for Health Policy Distribution of potential risk Distribution of population Socio-economic aspect GIS in GPE Risk mapping

Global Programme on Evidence for Health Policy Night time light GIS in GPE Risk mapping

Global Programme on Evidence for Health Policy Mortality Data Coverage GIS in GPE Thematic mapping The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved ©ESRI (background map)

Global Programme on Evidence for Health Policy AFRO Countries with health system profiles and NHA's GIS in GPE Thematic mapping The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved ©ESRI (background map)

Global Programme on Evidence for Health Policy GIS in GPE Thematic mapping The boundaries and names shown and the designations used on this map do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. © WHO All rights reserved ©ESRI (background map)

Global Programme on Evidence for Health Policy What are we expecting from this meeting ? A follow up of the First Interagency Meeting on GIS that was held in WHO HQ Geneva (June 1999) regarding: - standards (background maps, codification), - the legal aspect, - centralisation and dissemination.